MAPT and Alzheimer disease: While molecular imaging of tau deposits by PET initially focused on Alzheimer’s disease, the most common tauopathy, an increasing number of post-mortem and human studies are being conducted in 4R-tau positive parkinsonian syndromes (Coakeley and Strafella, 2017; Schonhaut et al., 2017).